New Tool Reveals Risks and Origins of Generic Drugs
Originally Published 20 days ago — by ProPublica
ProPublica investigated the FDA's limited testing of generic drugs, revealing irregularities and quality concerns in widely used medications like bupropion and metoprolol, which could compromise their effectiveness and patient safety, highlighting the agency's reliance on manufacturers and sporadic testing practices.